Aehr (AEHR) Q1 2025: WaferPak Revenue Hits 92% of Sales as Market Diversification Accelerates

2024-10-10 | By EarningsIQ Research

Aehr’s Q1 revealed a decisive shift toward recurring WaferPak revenue, now accounting for 92% of total sales, as the company’s test and burn-in solutions gain traction across emerging semiconductor markets. Management reaffirmed full-year guidance and outlined visible expansion in silicon carbide, gallium nitride, AI processors, and data storage, signaling a broader customer and application base. The InCal acquisition is already contributing, with integration and cross-selling opportunities progressing ahead of schedule.

Summary

• Recurring Revenue Dominance: WaferPak sales surged as a percent of revenue, deepening recurring stream visibility.
• Multi-Market Expansion: Engagements in silicon carbide, GaN, AI, and storage are materializing into new customer ramps.
• Execution Focus: Integration of InCal and operational upgrades position Aehr for scalable growth across cycles.

Business Overview

Aehr Test Systems designs and manufactures semiconductor test and burn-in equipment, specializing in wafer-level and package-level reliability screening for power electronics, AI processors, memory, and storage devices. The company’s revenue model is anchored by system sales and highly recurring WaferPak contactor sales, with major segments spanning silicon carbide (SiC), gallium nitride (GaN), AI/high-performance computing, and data storage. The recent acquisition of InCal Technology expands Aehr’s reach into high-power package burn-in for AI and medical applications.

Performance Analysis

First quarter results exceeded consensus on both revenue and non-GAAP net income, but headline revenue fell year-over-year as the SiC market cycled through a typical adoption pause. The standout metric was WaferPak revenue, which comprised 92% of total sales versus 55% a year ago, reflecting robust recurring demand from the installed base and new device qualifications. Gross margin expanded to 54.7%, fueled by the high-margin mix of WaferPak sales, while operating expenses remained tightly controlled despite ongoing investments in infrastructure and integration.

Backlog stood at $16.6 million, with InCal contributing a meaningful portion and longer lead times providing improved forward visibility. Cash levels decreased sequentially after the InCal acquisition, but Aehr remains debt-free and continues to earn incremental interest income in a high-rate environment. The company’s pipeline is broadening: management highlighted imminent customer ramps in SiC, first volume GaN orders, and a major AI processor evaluation that could represent more than 10% of annual revenue if adopted for production.

• WaferPak Mix Shift: Recurring consumables now dominate revenue, reducing dependence on lumpy system sales.
• Margin Expansion: Higher WaferPak mix drove non-GAAP gross margin up 600 basis points year-over-year.
• Customer Pipeline Broadening: Multiple new engagements in SiC, GaN, and AI processors are tracking toward production ramps.

With market diversification accelerating, Aehr’s financials reflect a business model transition from single-market exposure to a multi-pronged, recurring revenue engine. The company is now less exposed to any single customer or device cycle.

Executive Commentary

Strategic Positioning

1. Silicon Carbide: Stabilization and New Ramps

After a period of adjustment, SiC market momentum is resuming, with Aehr positioned as the low-cost leader for wafer-level burn-in. Management expects to add several new SiC customers this year, with initial system orders anticipated in early 2025 and production ramps in the back half, driven by EV, industrial, and data center demand. Importantly, OEM requirements for extended burn-in times are raising the bar for test complexity and volume, favoring Aehr’s solution.

2. GaN and AI Processor Penetration

First volume GaN customer negotiations are underway, with broadening interest from multiple suppliers. GaN, with a forecasted 40%+ CAGR, could become a major incremental market. In AI processors, a leading accelerator company is close to adopting Aehr’s Fox XP system for wafer-level burn-in, which could displace traditional package-level screening and represents a potential >10% customer in FY25.

3. InCal Acquisition: Cross-Selling and Market Expansion

InCal brings ultra-high power package burn-in for AI/HPC and medical applications, expanding Aehr’s portfolio and addressable market. Integration is ahead of plan, with cross-selling to Intel’s customer base and early volume orders from a hyperscale data center operator. The combined Fremont facility will drive operational leverage and scale.

4. Storage and Memory: New Growth Vectors

Hard disk drive and NAND flash benchmarks are advancing, with a key storage customer expected to ramp production this year and a leading flash manufacturer evaluating the Fox XP for wafer-level burn-in. These segments offer multi-year growth potential as reliability requirements intensify.

5. Operational Infrastructure and Supply Chain

ERP and supply chain upgrades, coupled with new contract manufacturing partnerships, are building a more robust foundation for both organic and inorganic growth. Aehr is investing in facility consolidation and internal controls to support long-term scalability.

Key Considerations

This quarter marks a pivotal transition for Aehr, as the company’s revenue model tilts sharply toward recurring consumables while its addressable market broadens across several high-growth semiconductor segments. Strategic investments in infrastructure, product capability, and M&A integration are positioning Aehr to capitalize on secular trends in electrification, AI, and data storage.

Key Considerations:

• Recurring Revenue Resilience: WaferPak sales now anchor the business, smoothing volatility from system sales and providing margin stability.
• Customer Concentration Easing: New SiC, GaN, and storage customers reduce reliance on legacy accounts, mitigating single-customer risk.
• Integration Synergy: InCal’s portfolio and customer base are accelerating cross-selling, with operational consolidation on track.
• Secular Demand Tailwinds: Electrification, AI compute, and reliability standards are driving new test and burn-in requirements across end markets.

Risks

Market timing for customer ramps in SiC, GaN, and AI remains subject to end-market adoption cycles, and any delays could impact near-term system sales. Competitive dynamics, especially as new entrants target test and burn-in for power semiconductors, could pressure pricing or erode share. While recurring WaferPak revenue provides a buffer, the transition to a multi-market model is still underway and execution risk remains around integration, customer onboarding, and scaling new verticals. Management’s guidance depends on successful conversion of current evaluations and pilot programs into volume orders.

Forward Outlook

For Q2, Aehr guided to:

• Continued high WaferPak revenue mix
• Initial system orders from new SiC and GaN customers

For full-year 2025, management reaffirmed guidance:

• Total revenue of at least $70 million
• Net profit before taxes of at least 10% of revenue

Management highlighted several factors that will shape results:

• 85% of annual revenue expected from wafer-level burn-in, 15% from package part burn-in (InCal)
• Potential for upside from storage, memory, and silicon photonics if customer ramps accelerate

Takeaways

Aehr’s Q1 results underscore a business model pivot toward recurring, high-margin consumables and a more diversified market footprint, reducing dependence on any single technology or customer cycle. Integration of InCal and ongoing infrastructure investments are positioning Aehr for scalable, multi-segment growth as semiconductor reliability demands intensify.

• Recurring Revenue Engine: WaferPak’s 92% revenue share signals a durable, margin-rich foundation for future growth.
• Market Expansion in Motion: Customer evaluations and pilot programs across SiC, GaN, AI, and storage are progressing toward production ramps, broadening the growth pipeline.
• Execution Watchpoints: Investors should monitor conversion of pilot programs into volume orders, integration milestones, and the pace of new customer ramps in emerging segments.

Conclusion

Aehr’s Q1 2025 marks a strategic inflection point, with recurring consumables revenue surging and a growing pipeline of new verticals. The company’s operational and portfolio investments are building a platform for multi-year growth, though execution on customer ramps and integration will remain key watchpoints for investors.

Industry Read-Through

Aehr’s results highlight a broader trend in the semiconductor capital equipment space: customers are prioritizing reliability and yield as device complexity and mission-critical applications proliferate, driving demand for advanced test and burn-in at both wafer and package level. The shift to recurring consumables revenue (WaferPak) mirrors a larger industry move toward installed-base monetization and margin resilience. Power semiconductors (SiC, GaN), AI accelerators, and storage devices are converging on higher reliability standards, suggesting that test and burn-in will be a secular growth engine for equipment vendors. Competitors and adjacent players should note the rising customer expectations for both system capability and service agility, as well as the operational leverage available from recurring revenue streams.

AEHR Technology Semiconductor Equipment Recurring Revenue WaferPak Power Electronics AI Acquisition